Literature DB >> 21264953

Microglia/macrophages promote glioma progression.

Haiyan Zhai1, Frank L Heppner, Stella E Tsirka.   

Abstract

Gliomas are highly aggressive and accompanied by numerous microglia/macrophages (MG/MP) in and about the tumor. Little is known about what MG/MP do in this setting, or whether modulating MG/MP activation might affect glioma progression. Here, we used a glioma-microglia in culture system to establish the effects the tumor and microglia have on each other. We assessed glioma progression in vivo after MG/MP ablation or in the setting of exaggerated MG/MP activation. We show that glioma cells activate microglia but inhibit their phagocytic activities. Local ablation of MG/MP in vivo decreased tumor size and improved survival curves. Conversely, pharmacological activation of MG/MP increased glioma size through stimulating tumor proliferation and inhibiting apoptosis. In agreement with recent reports, expression of the chemokine CCL21 is enhanced after MG/MP activation and correlates with tumor growth. Taken together, our findings demonstrate that inhibition of MG/MP activation may constitute a new and effective contribution towards suppressing glioma proliferation.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21264953      PMCID: PMC3080032          DOI: 10.1002/glia.21117

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  71 in total

Review 1.  Tuftsin: on the 30-year anniversary of Victor Najjar's discovery.

Authors:  I Z Siemion; A Kluczyk
Journal:  Peptides       Date:  1999       Impact factor: 3.750

2.  Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia.

Authors:  Angelika Rappert; Knut Biber; Christiane Nolte; Martin Lipp; Andreas Schubel; Bao Lu; Norma P Gerard; Craig Gerard; Hendrikus W G M Boddeke; Helmut Kettenmann
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

4.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.

Authors:  S Y Leung; M P Wong; L P Chung; A S Chan; S T Yuen
Journal:  Acta Neuropathol       Date:  1997-05       Impact factor: 17.088

5.  Microglia and tumor rejection.

Authors:  K Frei; U Malipiero; D Piani; A Fontana
Journal:  Neuropathol Appl Neurobiol       Date:  1994-04       Impact factor: 8.090

6.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.

Authors:  B Badie; J Schartner; J Klaver; J Vorpahl
Journal:  Neurosurgery       Date:  1999-05       Impact factor: 4.654

Review 7.  Molecular mechanisms of glioma cell migration and invasion.

Authors:  Tim Demuth; Michael E Berens
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

8.  Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG.

Authors:  S Goswami; A Gupta; S K Sharma
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

9.  Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.

Authors:  Nathan R Miselis; Zhijin J Wu; Nico Van Rooijen; Agnes B Kane
Journal:  Mol Cancer Ther       Date:  2008-03-28       Impact factor: 6.261

10.  Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.

Authors:  Madhuri Bhasin; Muzhou Wu; Stella E Tsirka
Journal:  BMC Immunol       Date:  2007-07-16       Impact factor: 3.615

View more
  111 in total

1.  Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells.

Authors:  Gregory J Baker; Maria G Castro; Pedro R Lowenstein
Journal:  J Vis Exp       Date:  2015-11-28       Impact factor: 1.355

2.  Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.

Authors:  Michael Iv; Peyman Samghabadi; Samantha Holdsworth; Andrew Gentles; Paymon Rezaii; Griffith Harsh; Gordon Li; Reena Thomas; Michael Moseley; Heike E Daldrup-Link; Hannes Vogel; Max Wintermark; Samuel Cheshier; Kristen W Yeom
Journal:  Radiology       Date:  2018-11-06       Impact factor: 11.105

Review 3.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

4.  BSSE: An open-source image processing tool for miniaturized microscopy.

Authors:  Jeonghwan Son; Biagio Mandracchia; Michael D Caponegro; Stella E Tsirka; Shu Jia
Journal:  Opt Express       Date:  2019-06-24       Impact factor: 3.894

5.  CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.

Authors:  Kien Pham; Defang Luo; Che Liu; Jeffrey K Harrison
Journal:  J Neuroimmunol       Date:  2012-03-16       Impact factor: 3.478

Review 6.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

7.  Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.

Authors:  Winnie W Pong; Samantha B Higer; Scott M Gianino; Ryan J Emnett; David H Gutmann
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

8.  Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Authors:  Nadja Osterberg; Napoleone Ferrara; Jean Vacher; Simone Gaedicke; Gabriele Niedermann; Astrid Weyerbrock; Soroush Doostkam; Hans-Eckart Schaefer; Karl H Plate; Marcia Regina Machein
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

9.  S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Authors:  Huaqing Wang; Leying Zhang; Ian Y Zhang; Xuebo Chen; Anna Da Fonseca; Shihua Wu; Hui Ren; Sam Badie; Sam Sadeghi; Mao Ouyang; Charles D Warden; Behnam Badie
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

Review 10.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.